DNA methylation predicts infection risk in kidney transplant recipients
Life Science Alliance · 2025
DOI: 10.26508/lsa.202403124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Fei-Man Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: DNA Methylation, Kidney Transplantation, Infections. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, UCLA QCBio Collaboratory, IDRE postdoctoral fellowships.
Abstract (Originalsprache)
Kidney transplantation (KTx) is the method of choice for treating kidney failure. Identifying biomarkers predictive of transplant (Tx) outcomes is critical to optimize KTx; however, the immunosuppressive therapies required after KTx must also be considered. We applied targeted bisulfite sequencing (TBS-seq) to PBMCs isolated from 90 patients, with samples collected pre- and post-Tx (day 90), to measure DNA methylation changes. Our findings indicate that the PBMC DNA methylome is significantly affected by induction immunosuppression with anti-thymocyte globulin (ATG). We discovered that the risk of infection can be predicted using DNA methylation profiles, but not gene expression profiles. Specifically, 515 CpG loci associated with 275 genes were significantly impacted by ATG induction, even after accounting for age, sex, and cell-type composition. Notably, ATG-associated hyper-methylation down-regulates genes critical for immune response. In conclusion, this clinical omics study reveals that the immunosuppressant ATG profoundly impacts the DNA methylome of KTx recipients and identifies biomarkers that could be used in pre-Tx screening of patients vulnerable to infection, thereby informing immunosuppression strategies post-Tx.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.
- Institute for Quantitative and Computational Biosciences - The Collaboratory, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA matteop@mcdb.ucla.edu.
- Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA JSchaenman@mednet.ucla.edu.
ORCID-Profile: Fei-Man Hsu, Matteo Pellegrini, Joanna M Schaenman
Förderung
- NIA NIH HHS
- UCLA QCBio Collaboratory
- IDRE postdoctoral fellowships
Zitieren
APA
Hsu, F. M., Pickering, H., Rubbi, L., Thompson, M., Reed, E. F., Pellegrini, M., & Schaenman, J. M. (2025). DNA methylation predicts infection risk in kidney transplant recipients. Life Science Alliance. https://doi.org/10.26508/lsa.202403124
Vancouver
Hsu FM, Pickering H, Rubbi L, Thompson M, Reed EF, Pellegrini M, et al. DNA methylation predicts infection risk in kidney transplant recipients. Life Science Alliance. 2025. doi:10.26508/lsa.202403124
BibTeX
@article{Hsu2025,
author = {Hsu, Fei-Man and Pickering, Harry and Rubbi, Liudmilla and Thompson, Michael and Reed, Elaine F and Pellegrini, Matteo and Schaenman, Joanna M},
title = {DNA methylation predicts infection risk in kidney transplant recipients},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202403124}
}
EUVIMED